Supreme Court Upholds Copaxone Patent

The ruling prevents Sandoz from launching a generic version of the multiple sclerosis drug. Read More

Invitae, Myriad Settle BRCA 1 and 2 Genetic Testing Lawsuit

Myriad alleged that Invitae’s test infringed on its patents for BRCA 1 and 2 tests. Read More
The Solutions Center